Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT00380198
Other study ID # BMS068645-305
Secondary ID EudraCT #2006-00
Status Terminated
Phase Phase 3
First received September 21, 2006
Last updated January 31, 2017
Start date July 2006
Est. completion date November 2006

Study information

Verified date January 2017
Source Forest Laboratories
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this clinical research study is to compare Apadenoson and adenosine to treadmill exercise stress SPECT MPI


Recruitment information / eligibility

Status Terminated
Enrollment 1500
Est. completion date November 2006
Est. primary completion date November 2006
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Clinically appropriate for exercise stress testing

Exclusion Criteria:

- Contraindication to adenosine stress or inability to perform treadmill exercise test

Study Design


Intervention

Drug:
Apadenoson


Locations

Country Name City State
United States Local Institution Albany New York
United States Local Institution Auburn Maine
United States Local Institution Aurora Illinois
United States Local Institution Bannockburn Illinois
United States Local Institution Baton Rouge Louisiana
United States Local Institution Bridgeport Connecticut
United States Local Institution Chattanooga Tennessee
United States Local Institution Cincinnati Ohio
United States Local Institution Fort Lauderdale Florida
United States Local Institution Gainsville Florida
United States Local Institution Guilford Connecticut
United States Local Institution Honolulu Hawaii
United States Local Institution Houston Texas
United States Local Institution Huntsville Alabama
United States Local Institution Indianapolis Indiana
United States Local Institution Jacksonville Florida
United States Local Institution Jacksonville Florida
United States Local Institution Jacksonville Beach Florida
United States Local Institution Johnson City Tennessee
United States Local Institution Jupiter Florida
United States Local Institution Kansas City Missouri
United States Local Institution LaGrange Illinois
United States Local Institution Lombard Illinois
United States Local Institution Lorain Ohio
United States Local Institution Louisville Kentucky
United States Local Institution Madison Wisconsin
United States Local Institution Miami Florida
United States Local Institution Newark Delaware
United States Local Institution Overland Park Kansas
United States Local Institution Richmond Virginia
United States Local Institution Sandusky Ohio
United States Local Institution Santa Rosa California
United States Local Institution Simpsonville South Carolina
United States Local Institution St. Louis Park Minnesota
United States Local Institution Stuart Florida
United States Local Institution Tamarac Florida
United States Local Institution Tupelo Mississippi
United States Local Institution West Islip New York
United States Local Institution Westlake Ohio
United States Local Institution Westminster Maryland
United States Local Institution Winfield Illinois
United States Local Institution Wyomissing Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
Forest Laboratories

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Agreement between MPI Summed Stress Scores for extent and severity of disease
Secondary Comparison of imaging data to 6 month event data or angiography
See also
  Status Clinical Trial Phase
Recruiting NCT06030596 - SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
Completed NCT04080700 - Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
Recruiting NCT03810599 - Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study N/A
Recruiting NCT06002932 - Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions. N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT04242134 - Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions N/A
Recruiting NCT05308719 - Nasal Oxygen Therapy After Cardiac Surgery N/A
Completed NCT04556994 - Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients. N/A
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT05023629 - STunning After Balloon Occlusion N/A
Completed NCT04941560 - Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
Completed NCT04006288 - Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease Phase 4
Completed NCT01860274 - Meshed Vein Graft Patency Trial - VEST N/A
Recruiting NCT06174090 - The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients N/A
Completed NCT03968809 - Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
Terminated NCT03959072 - Cardiac Cath Lab Staff Radiation Exposure
Recruiting NCT04566497 - Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up. N/A
Recruiting NCT05065073 - Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography Phase 4
Completed NCT05096442 - Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions N/A